These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8121387)

  • 21. [Treatment with monoclonal anti-endotoxin antibodies of patients with sepsis caused by Gram-negative bacteria].
    Ned Tijdschr Geneeskd; 1991 Jul; 135(28):1289-91. PubMed ID: 1861770
    [No Abstract]   [Full Text] [Related]  

  • 22. Failure to inhibit endotoxin-induced uveitis with antibodies that neutralize tumor necrosis factor.
    Rosenbaum JT; Boney RS
    Reg Immunol; 1993; 5(5):299-303. PubMed ID: 8148240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preventive interruption of the administration of HA-1A monoclonal antibody against endotoxin].
    Torrabadella de Reynoso P; Trilla A; Salgado A; Ribas J
    Med Clin (Barc); 1993 Apr; 100(13):518. PubMed ID: 8479241
    [No Abstract]   [Full Text] [Related]  

  • 24. Large dose ketamine inhibits lipopolysaccharide-induced acute lung injury in rats.
    Yang J; Li W; Duan M; Zhou Z; Lin N; Wang Z; Sun J; Xu J
    Inflamm Res; 2005 Mar; 54(3):133-7. PubMed ID: 15883747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiendotoxin therapy in sepsis.
    Colletti RC; Dew RB; Goulart AE
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):345-54. PubMed ID: 8398040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Monoclonal antibodies against endotoxin in septicemia. Marketing or scientific evaluation?].
    Waage A
    Tidsskr Nor Laegeforen; 1994 Mar; 114(8):951-3. PubMed ID: 8191476
    [No Abstract]   [Full Text] [Related]  

  • 27. Endotoxin reduces specific pulmonary uptake of radiolabeled monoclonal antibody to angiotensin-converting enzyme.
    Muzykantov VR; Puchnina EA; Atochina EN; Hiemish H; Slinkin MA; Meertsuk FE; Danilov SM
    J Nucl Med; 1991 Mar; 32(3):453-60. PubMed ID: 1848608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Life-saving immunotherapy with cross-reactive monoclonal antibodies against endotoxin: a critical evaluation of experimental and clinical studies.
    Cornelissen JJ; Schellekens JF; Kraaijeveld CA; Verhoef J
    Neth J Med; 1991 Oct; 39(3-4):170-6. PubMed ID: 1791879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis.
    Masubuchi Y; Horie T
    Drug Metab Dispos; 2004 Apr; 32(4):437-41. PubMed ID: 15039297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of anti-interleukin (IL)-6 antibody against endotoxin, associated with paradoxically increased IL-6 levels.
    Heremans H; Dillen C; Put W; Van Damme J; Billiau A
    Eur J Immunol; 1992 Sep; 22(9):2395-401. PubMed ID: 1381315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibody against CD11b/CD18 inhibits endotoxin-induced uveitis.
    Whitcup SM; DeBarge LR; Rosen H; Nussenblatt RB; Chan CC
    Invest Ophthalmol Vis Sci; 1993 Mar; 34(3):673-81. PubMed ID: 8095493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lessons learned from clinical trials on monoclonal anti-endotoxin antibody.
    Weil MH
    Arch Intern Med; 1994 Jun; 154(11):1183. PubMed ID: 8203986
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of anti-lipid A monoclonal antibody (E5) on microcirculatory function during lipopolysaccharide shock.
    Schwartz RW; Arden WA; Pofahl W; Derbin M; Oremus R; Greenberg RN; Gross DR
    J Surg Res; 1993 May; 54(5):474-9. PubMed ID: 8361172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical detection of endotoxin in endotoxemic rats.
    Yasui M; Nakao A; Yuuki T; Harada A; Nonami T; Takagi H
    Hepatogastroenterology; 1995; 42(5):683-90. PubMed ID: 8751235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Protective effect of monoclonal antibody of tumor necrosis factor-alpha for vital organs in a model suffering from intestinal ischemia and reperfusion injury].
    Yao YM
    Zhonghua Wai Ke Za Zhi; 1993 Aug; 31(8):497-500. PubMed ID: 8112180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed rats.
    Rabinovici R; Bugelski PJ; Esser KM; Hillegass LM; Griswold DE; Vernick J; Feuerstein G
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1550-7. PubMed ID: 8263817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lower limb ischaemia-reperfusion injury causes endotoxaemia and endogenous antiendotoxin antibody consumption but not bacterial translocation.
    Yassin MM; Barros D'Sa AA; Parks TG; Soong CV; Halliday MI; McCaigue MD; Erwin PJ; Rowlands BJ
    Br J Surg; 1998 Jun; 85(6):785-9. PubMed ID: 9667708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies.
    Barriere SL; Guglielmo BJ
    Clin Pharm; 1992 Mar; 11(3):223-35. PubMed ID: 1611812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endotoxin antibody for sepsis in infants.
    Nadel S; Klein N; Heyderman R; Levin M
    Lancet; 1992 Mar; 339(8794):678. PubMed ID: 1347362
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-endotoxin therapy and the management of sepsis.
    Baumgartner JD
    J Antimicrob Chemother; 1992 Apr; 29(4):360-3. PubMed ID: 1607325
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.